文献速递乳腺癌妇科肿瘤泌尿男性生殖肿瘤

2020年撒哈拉以南非洲的癌症:国家负担、数据缺口与未来需求的当前估计综述

Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs.
PubMed 文献 · Lancet Oncol · 2022-05-09

该综述基于国际癌症研究机构GLOBOCAN 2020数据库,提取撒哈拉以南非洲48国的癌症发病与死亡估计值,总结区域负担模式。2020年估计新发癌症801 392例、死亡520 158例,乳腺癌和宫颈癌合计占男女诊断癌症的十分之三。作者认为各国需建设本地数据生产能力,癌症登记应优先获得可持续投资。

要点

  • 2020年撒哈拉以南非洲估计新发癌症801 392例、癌症死亡520 158例。
  • 乳腺癌(女性129 400例)和宫颈癌(110 300例)合计占男女诊断癌症的十分之三。
  • 女性75岁前患癌累积风险14.1%,其中乳腺癌4.1%、宫颈癌3.5%合计占一半。

核心结论

  • 估计显示撒哈拉以南非洲主要癌症存在显著地理差异。
  • 合理的癌症控制规划要求各国自身建设数据生产、分析与解读能力。
  • 癌症登记可提供重要信息,应作为该区域可持续投资的优先事项。

研究设计与样本

  • 基于国际癌症研究机构GLOBOCAN数据库2020年数据,提取撒哈拉以南非洲国家的新发癌症病例和死亡数。
  • GLOBOCAN纳入48个国家(要求2020年国家人口大于150 000人)。
  • 25个国家直接使用截至2019年的较近期癌症登记数据产生国家发病估计,16个国家因缺乏此类数据而基于邻国数据估计。
  • 以表格和图呈现新发病例与死亡估计数、每10万人年的年龄标化发病或死亡率和75岁前患癌或死于癌症的累积风险。
  • 资金:无。

主要发现

  • 2020年撒哈拉以南非洲估计发生801 392例新发癌症和520 158例癌症死亡。
  • 乳腺癌(女性129 400例)和宫颈癌(110 300例)合计占男女诊断癌症的十分之三。
  • 乳腺癌和宫颈癌分别在最常见的癌症中排名第一的国家数为28个和19个。
  • 男性中前列腺癌发病居首(77 300例),其次为肝癌(24 700例)和结直肠癌(23 400例);前列腺癌是40个撒哈拉以南非洲国家男性发病最多的癌症。
  • 女性75岁前患癌累积风险为14.1%,其中乳腺癌(4.1%)和宫颈癌(3.5%)合计占该风险的一半;男性相应累积发病风险较低(12.2%),前列腺癌占该风险的三分之一(4.2%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With the cancer burden rising in sub-Saharan Africa, countries in the region need surveillance systems to measure the magnitude of the problem and monitor progress in cancer control planning. Based on the national estimates built from data provided by cancer registries in sub-Saharan Africa, we summarise key patterns of the regional burden and argue for investments in locally produced data. METHODS: To present national estimates of the cancer incidence and mortality burden in sub-Saharan Africa countries, new cancer cases and deaths were extracted from International Agency for Research on Cancers' GLOBOCAN database for the year 2020. Given weak vital statistics systems, almost all of the information on the cancer burden in sub-Saharan Africa was derived from population-based cancer registries. Of the 48 countries included in GLOBOCAN (national populations must be larger than 150 000 inhabitants in 2020), relatively recent cancer registry data (up to 2019) were directly used to produce national incidence estimates in 25 countries, while the absence of such data for 16 meant that estimates were based on data from neighbouring countries. Tables and figures present the estimated numbers of new cases and deaths, as well as age-standardised (incidence or mortality) rates per 100 000 person-years and the cumulative risk of developing or dying from cancer before the age of 75 years. FINDINGS: 801 392 new cancer cases and 520 158 cancer deaths were estimated to have occurred in sub-Saharan Africa in 2020. Cancers of the breast (129 400 female cases) and cervix (110 300 cases) were responsible for three in ten of the cancers diagnosed in both sexes. Breast and cervical cancer were the most common cancers, ranking first in 28 and 19 countries, respectively. In men, prostate cancer led in terms of incidence (77 300 cases), followed by liver cancer (24 700 cases) and colorectal cancer (23 400 cases). Prostate cancer was the leading incident cancer in men in 40 sub-Saharan Africa countries. The risk of a woman in sub-Saharan Africa developing cancer by the age of 75 years was 14·1%, with breast cancer (4·1%) and cervical cancer (3·5%) responsible for half of this risk. For men, the corresponding cumulative incidence was lower (12·2%), with prostate cancer responsible for a third of this risk (4·2%). Cervical cancer was the leading form of cancer death among women in 27 countries, followed by breast cancer (21 countries). Prostate cancer led as the most common type of cancer death in 26 countries, with liver cancer ranking second (11 countries). INTERPRETATION: The estimates indicate substantial geographical variations in the major cancers in sub-Saharan Africa. Rational cancer control planning requires capacity to be built for data production, analysis, and interpretation within the countries themselves. Cancer registries provide important information in this respect and should be prioritised for sustainable investment in the region. FUNDING: None.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Bray F, Parkin DM. Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs. Lancet Oncol. 2022. PMID: 35550275. doi:10.1016/S1470-2045(22)00270-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。